Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Replimune Group Inc buy BMO Capital Markets

Start price
€15.40
22.11.24 / 50%
Target price
€17.31
22.11.25
Performance (%)
-49.03%
End price
€7.85
23.11.25
Summary
This prediction ended on 23.11.25 with a price of €7.85. Massive losses of -49.03% were the result for the BUY prediction by BMO_Capital_Markets. BMO_Capital_Markets has a follow-up prediction for Replimune Group Inc where he still thinks Replimune Group Inc is a Buy. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Replimune Group Inc -7.865% -7.865% -29.310%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by BMO_Capital_Markets for this prediction

In the thread Replimune Group Inc diskutieren
Prediction Buy
Perf. (%) -49.03%
Target price 17.307
Change
Ends at 22.11.25

Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $14.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat

In the thread Trading Replimune Group Inc
Prediction Buy
Perf. (%) -49.03%
Target price 17.307
Change
Ends at 22.11.25

Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten

Current prediction by BMO_Capital_Markets for Replimune Group Inc

buy
Replimune Group Inc

Start price
Target price
Perf. (%)
€12.90
22.01.25
€25.92
22.01.26
-36.43%
12.12.25

Stopped prediction by BMO_Capital_Markets for Replimune Group Inc

Replimune Group Inc

Start price
Target price
Perf. (%)
€2.40
23.07.25
€1.70
23.07.26
262.50%
12.12.25